Summary
Elara Capital has initiated coverage on four pharmaceutical stocks, assigning various ratings. Alkem Laboratories is its top pick for margin recovery, while Eris Lifesciences and Mankind Pharma are expected to benefit from portfolio expansion and acquisitions.